Prevention of atrial fibrillation after cardiac surgery
Keywords:
Disease Prevention, Atrial Fibrillation, Postoperative Period, Cardiac SurgeryAbstract
Atrial fibrillation is the most commonly found arrhythmia after cardiac surgery. Although usually self-limiting, it represents an important predictor of increased patient morbidity, mortality, and health care costs. Numerous studies have attempted to determine the underlying mechanisms of postoperative atrial fibrillation with different results. A multifactorial pathophysiology is suggested, with inflammation and postoperative adrenergic activation recognized as important contributing factors. The management is complicated by a lack of data on the outcomes of different therapeutic interventions in this population. This article reviews the literature focusing on interventions to prevent postoperative atrial fibrillation.
Downloads
Download data is not yet available.
References
1. Villareal RP, Hariharan R, Liu BC, et al. Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol. 2004;43(5):742-8. DOI: http://dx.doi.org/10.1016/j.jacc.2003.11.023
2. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539-49. DOI: http://dx.doi.org/10.1016/0003-4975(93)90894-N 3. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation. 1991;84(5 Suppl):III236-44.
4. Mahoney EM, Thompson TD, Veledar E, et al. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol. 2002;40(4):737-45. DOI: http://dx.doi.org/10.1016/S0735- 1097(02)02003-X
5. Mariscalco G, Engström KG. Atrial fibrillation after cardiac surgery: Risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol. 2008;129(3):354-62. DOI: http://dx.doi. org/10.1016/j.ijcard.2007.07.123
6. Zaman AG, Archbold RA, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000;101(12):1403-8. DOI: http://dx.doi.org/10.1161/01. CIR.101.12.1403
7. 2011 Writing Group Members, Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:104- 23. DOI: http://dx.doi.org/10.1161/CIR.0b013e3181fa3cf4
8. Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI: http://dx.doi.org/10.1093/eurheartj/ehw210
9. Balser JR. Pro: All patients should receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(1):98-100. DOI: http://dx.doi.org/10.1016/S1053- 0770(99)90182-9
10. Weber UK, Osswald S, Huber M, et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J. 1998;19(5):794-800.
11. Hogue CW Jr. Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(1):101-4. DOI: http://dx.doi.org/10.1016/S1053- 0770(99)90183-0
12. Bradley D, Creswell LL, Hogue CW, et al. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2 Suppl):39S-47S. DOI: http://dx.doi.org/10.1378/ chest.128.2_suppl.39S
13. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study. Am Heart J. 2003;145(2):226-32. DOI: http://dx.doi.org/10.1067/ mhj.2003.147
14. Ferguson TB, Coombs LP, Peterson ED, Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287(17):2221-7.
15. Merritt JC, Niebauer M, Tarakji K, et al. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol. 2003;92(6):735-6. DOI: http://dx.doi.org/10.1016/S0002-9149(03)00842-7
16. Maniar PB, Balcetyte-Harris N, Tamis JE, et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in highrisk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev. 2003;7(2):158-61. DOI: http://dx.doi. org/10.1023/A:1027467617722
17. Silva RG, Lima GG, Laranjeira A, et al. Fatores de risco e morbimortalidade associados à fibrilação atrial no pós-operatório de cirurgia cardíaca. Arq Bras Cardiol. 2004;83(2):99-104. DOI: http://dx.doi.org/10.1590/S0066- 782X2004001400002
18. Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;(4):CD003611.
19. Khan J, Khan N, Loisa E, et al. Increasing Occurrence of Postoperative Atrial Fibrillation in Contemporary Cardiac Surgery. J Cardiothorac Vasc Anesth. 2016;30(5):1302-7. DOI: http://dx.doi.org/10.1053/j. jvca.2016.02.013
20. Gomes JA, Ip J, Santoni-Rugiu F, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;34(2):334-9. DOI: http://dx.doi.org/10.1016/ S0735-1097(99)00213-2
21. Suttorp MJ, Kingma JH, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol. 1991;68(11):1163-9. DOI: http:// dx.doi.org/10.1016/0002-9149(91)90188-Q
22. Sanjuán R, Blasco M, Carbonell N, et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2004;77(3):838-43. DOI: http://dx.doi.org/10.1016/j. athoracsur.2003.06.014
23. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27(23):2846-57. DOI: http://dx.doi. org/10.1093/eurheartj/ehl272
24. Polster P, Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976;25(2):131-4. DOI: http://dx.doi. org/10.1016/0006-2952(76)90279-3
25. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet (London, England). 2001;357(9259):830-6. DOI: http://dx.doi.org/10.1016/S0140- 6736(00)04196-9
26. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve
Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA. 2005;294(24):3093-100. DOI: http://dx.doi.org/10.1001/jama.294.24.3093
27. Gillespie EL, Coleman CI, Sander S, et al. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother. 2005;39(9):1409-15. DOI: http://dx.doi.org/10.1345/aph.1E592
28. Aasbo JD, Lawrence AT, Krishnan K, Kim MH , Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann lntern Med. 2005;143(5): 327-36. DOI: http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00008
29. Patel AA, White CM, Gillespie EL, et al. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm. 2006;63(9):829-37. DOI: http://dx.doi.org/10.2146/ ajhp050454
30. Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013;(1):CD003611.
31. Chatterjee S, Sardar P, Mukherjee D, et al. Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta-analysis. Pacing Clin Electrophysiol. 2013;36(8):1017-23. DOI: http://dx.doi.org/10.1111/ pace.12140
32. Zhu J, Wang C, Gao D, et al. Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. Intern Med J. 2012;42(10):1078-87. DOI: http://dx.doi. org/10.1111/j.1445-5994.2012.02844.x
33. DiDomenico RJ, Massad MG. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg. 2005;79(2):728- 40. DOI: http://dx.doi.org/10.1016/j.athoracsur.2004.03.037
34. Reddy P, Dunn AB, White CM, et al. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy. 2002;22(1):75-80. DOI: http://dx.doi. org/10.1592/phco.22.1.75.33498
35. Gold MR, O’Gara PT, Buckley MJ, et al. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol. 1996;78(9):975-9. DOI: http://dx.doi.org/10.1016/S0002- 9149(96)00519-X
36. Merrick AF, Odom NJ, Keenan DJ, et al. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial. Eur J Cardiothorac Surg. 1995;9(3):146-9. DOI: http://dx.doi.org/10.1016/S1010-7940(05)80062-4
37. Wijeysundera DN, Beattie WS, Rao V, et al. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol. 2003;41(9):1496-505. DOI: http://dx.doi.org/10.1016/ S0735-1097(03)00191-8
38. Solomon AJ, Berger AK, Trivedi KK, et al. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg. 2000;69(1):126-9. DOI: http://dx.doi.org/10.1016/S0003- 4975(99)01187-X
39. Wistbacka JO, Koistinen J, Karlqvist KE, et al. Magnesium substitution in elective coronary artery surgery: a double-blind clinical study. J Cardiothorac Vasc Anesth. 1995;9(2):140-6. DOI: http://dx.doi. org/10.1016/S1053-0770(05)80184-3
40. Zangrillo A, Landoni G, Sparicio D, et al. Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: a randomized controlled study. J Cardiothorac Vasc Anesth. 2005;19(6):723-8. DOI: http://dx.doi.org/10.1053/j. jvca.2005.02.015
41. Miller S, Crystal E, Garfinkle M, et al. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart. 2005;91(5):618- 23. DOI: http://dx.doi.org/10.1136/hrt.2004.033811
42. De Oliveira GS Jr, Knautz JS, Sherwani S, et al. Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2012;26(4):643-50. DOI: http://dx.doi.org/10.1053/j. jvca.2012.03.012
43. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of the P-wave signalaveraged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;88(6):2618-22. DOI: http://dx.doi.org/10.1161/01. CIR.88.6.2618
44. Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI: http://dx.doi.org/10.1093/eurheartj/ehw210
45. Archbold RA, Schilling RJ. Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature. Heart. 2004;90(2):129-33. DOI: http://dx.doi.org/10.1136/ hrt.2003.015412
46. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7(9):833-42. DOI: http://dx.doi. org/10.1111/j.1540-8167.1996.tb00596.x
47. Gillis AM, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation. 1999;99(19):2553- 8. DOI: http://dx.doi.org/10.1161/01.CIR.99.19.2553
48. Prakash A, Delfaut P, Krol RB, et al. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol. 1998;82(10):1197-204. DOI: http://dx.doi. org/10.1016/S0002-9149(98)00604-3
49. Daubert JC, Mabo P. Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace? J Am Coll Cardiol. 2000;35(6):1423-7.
50. Fan K, Lee K, Lau C-P. Mechanisms of biatrial pacing for prevention of postoperative atrial fibrillation--insights from a clinical trial. Card Electrophysiol Rev. 2003;7(2):147-53. DOI: http://dx.doi. org/10.1023/A:1027463516813
51. Fan K, Lee KL, Chiu CS, et al. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation. 2000;102(7):755-60. DOI: http://dx.doi.org/10.1161/01. CIR.102.7.755
52. Daoud EG, Dabir R, Archambeau M, et al. Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation. 2000;102(7):761-5. DOI: http://dx.doi.org/10.1161/01.CIR.102.7.761
53. Levy T, Fotopoulos G, Walker S, et al. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation. 2000;102(12):1382-7. DOI: http://dx.doi.org/10.1161/01.CIR.102.12.1382
54. Greenberg MD, Katz NM, Iuliano S, et al. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol. 2000;35(6):1416-22. DOI: http://dx.doi.org/10.1016/S0735- 1097(00)00610-0
55. Gerstenfeld EP, Khoo M, Martin RC, et al. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol. 2001;5(3):275-83. DOI: http://dx.doi. org/10.1023/A:1011412715439
56. Blommaert D, Gonzalez M, Mucumbitsi J, et al. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol. 2000;35(6):1411-5. DOI: http:// dx.doi.org/10.1016/S0735-1097(00)00608-2
57. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg. 1989;97(6):821-5.
58. El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 2010;55(13):1370-6. DOI: http://dx.doi.org/10.1016/j. jacc.2009.10.058
59. Phan K, Ha HSK, Phan S, et al. New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2015;48(6):817-24. DOI: http://dx.doi.org/10.1093/ejcts/ezu551
60. Chung MK. Proarrhythmic effects of post-operative pacing intended to prevent atrial fibrillation: evidence from a clinical trial. Card Electrophysiol Rev. 2003;7(2):143-6. DOI: http://dx.doi.org/10.1023/A:1027411532743
61. Rezaei Y, Gholami-Fesharaki M, Dehghani MR, et al. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther. 2016;21(2):167-76. DOI: http://dx.doi. org/10.1177/1074248415602557
62. Carrascal Y, Arnold RJ, De la Fuente L, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the ROFACE trial (PROphylaxis of postoperative atrial Fibrillation AfterCardiac surgEry). J Arrhythmia. 2016;32(3):191-7. DOI: http://dx.doi. org/10.1016/j.joa.2016.01.010
63. Zheng Z, Jayaram R, Jiang L, et al. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. 2016;374(18):1744-53. DOI: http://dx.doi. org/10.1056/NEJMoa1507750
64. Korantzopoulos P, Kolettis T, Siogas K, et al. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit. 2003;9(9):RA225-9.
65. Baker WL, Coleman CI. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am J Health Pharm. 2016;73(24):2056-66. DOI: http://dx.doi.org/10.2146/ajhp160066
66. Jahangiri A, Leifert WR, Patten GS, et al. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem. 2000;206(1-2):33-41. DOI: http://dx.doi. org/10.1023/A:1007025007403
67. Sarrazin J-F, Comeau G, Daleau P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol. 2007;50(15):1505- 12. DOI: http://dx.doi.org/10.1016/j.jacc.2007.05.046
68. Zhang B, Zhen Y, Tao A, et al. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated metaanalysis of randomized controlled trials. J Cardiol. 2014;63(1):53-9. DOI: http://dx.doi.org/10.1016/j.jjcc.2013.06.014
69. Mariani J, Doval HC, Nul D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2013;2(1):e005033. DOI: http://dx.doi.org/10.1161/JAHA.112.005033
70. Cheruku KK, Ghani A, Ahmad F, et al. Efficacy of nonsteroidal antiinflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol. 2004;7(1):13-8. DOI: http://dx.doi.org/10.1111/j.1520-037X.2004.3117.x
71. Halonen J, Halonen P, Järvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA.
2007;297(14):1562-7. DOI: http://dx.doi.org/10.1001/jama.297.14.1562
72. Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, et al. Protective ffects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth. 2011;25(1):156-65. DOI: http://dx.doi.org/10.1053/j.jvca.2010.03.015
73. Viviano A, Kanagasabay R, Zakkar M. Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery? Interact Cardiovasc Thorac Surg. 2014;18(2):225-9.
74. Trivedi C, Sadadia M. Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis. Indian J Pharmacol. 2014;46(6):590-5. DOI: http://dx.doi.org/10.4103/0253-7613.144905
75. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016-23. DOI: http://dx.doi.org/10.1001/jama.2014.11026
2. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993;56(3):539-49. DOI: http://dx.doi.org/10.1016/0003-4975(93)90894-N 3. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery. A meta-analysis of randomized control trials. Circulation. 1991;84(5 Suppl):III236-44.
4. Mahoney EM, Thompson TD, Veledar E, et al. Cost-effectiveness of targeting patients undergoing cardiac surgery for therapy with intravenous amiodarone to prevent atrial fibrillation. J Am Coll Cardiol. 2002;40(4):737-45. DOI: http://dx.doi.org/10.1016/S0735- 1097(02)02003-X
5. Mariscalco G, Engström KG. Atrial fibrillation after cardiac surgery: Risk factors and their temporal relationship in prophylactic drug strategy decision. Int J Cardiol. 2008;129(3):354-62. DOI: http://dx.doi. org/10.1016/j.ijcard.2007.07.123
6. Zaman AG, Archbold RA, Helft G, et al. Atrial fibrillation after coronary artery bypass surgery: a model for preoperative risk stratification. Circulation. 2000;101(12):1403-8. DOI: http://dx.doi.org/10.1161/01. CIR.101.12.1403
7. 2011 Writing Group Members, Wann LS, Curtis AB, January CT, et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;123:104- 23. DOI: http://dx.doi.org/10.1161/CIR.0b013e3181fa3cf4
8. Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI: http://dx.doi.org/10.1093/eurheartj/ehw210
9. Balser JR. Pro: All patients should receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(1):98-100. DOI: http://dx.doi.org/10.1016/S1053- 0770(99)90182-9
10. Weber UK, Osswald S, Huber M, et al. Selective versus non-selective antiarrhythmic approach for prevention of atrial fibrillation after coronary surgery: is there a need for pre-operative risk stratification? A prospective placebo-controlled study using low-dose sotalol. Eur Heart J. 1998;19(5):794-800.
11. Hogue CW Jr. Con: All patients should not receive pharmacologic prophylaxis for atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth. 1999;13(1):101-4. DOI: http://dx.doi.org/10.1016/S1053- 0770(99)90183-0
12. Bradley D, Creswell LL, Hogue CW, et al. Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005;128(2 Suppl):39S-47S. DOI: http://dx.doi.org/10.1378/ chest.128.2_suppl.39S
13. Connolly SJ, Cybulsky I, Lamy A, et al. Double-blind, placebo-controlled, randomized trial of prophylactic metoprolol for reduction of hospital length of stay after heart surgery: The β-Blocker Length Of Stay (BLOS) study. Am Heart J. 2003;145(2):226-32. DOI: http://dx.doi.org/10.1067/ mhj.2003.147
14. Ferguson TB, Coombs LP, Peterson ED, Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA. 2002;287(17):2221-7.
15. Merritt JC, Niebauer M, Tarakji K, et al. Comparison of effectiveness of carvedilol versus metoprolol or atenolol for atrial fibrillation appearing after coronary artery bypass grafting or cardiac valve operation. Am J Cardiol. 2003;92(6):735-6. DOI: http://dx.doi.org/10.1016/S0002-9149(03)00842-7
16. Maniar PB, Balcetyte-Harris N, Tamis JE, et al. Intravenous versus oral beta-blockers for prevention of post-CABG atrial fibrillation in highrisk patients identified by signal-averaged ECG: lessons of a pilot study. Card Electrophysiol Rev. 2003;7(2):158-61. DOI: http://dx.doi. org/10.1023/A:1027467617722
17. Silva RG, Lima GG, Laranjeira A, et al. Fatores de risco e morbimortalidade associados à fibrilação atrial no pós-operatório de cirurgia cardíaca. Arq Bras Cardiol. 2004;83(2):99-104. DOI: http://dx.doi.org/10.1590/S0066- 782X2004001400002
18. Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2004;(4):CD003611.
19. Khan J, Khan N, Loisa E, et al. Increasing Occurrence of Postoperative Atrial Fibrillation in Contemporary Cardiac Surgery. J Cardiothorac Vasc Anesth. 2016;30(5):1302-7. DOI: http://dx.doi.org/10.1053/j. jvca.2016.02.013
20. Gomes JA, Ip J, Santoni-Rugiu F, et al. Oral d,l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 1999;34(2):334-9. DOI: http://dx.doi.org/10.1016/ S0735-1097(99)00213-2
21. Suttorp MJ, Kingma JH, Peels HO, et al. Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. Am J Cardiol. 1991;68(11):1163-9. DOI: http:// dx.doi.org/10.1016/0002-9149(91)90188-Q
22. Sanjuán R, Blasco M, Carbonell N, et al. Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg. 2004;77(3):838-43. DOI: http://dx.doi.org/10.1016/j. athoracsur.2003.06.014
23. Burgess DC, Kilborn MJ, Keech AC. Interventions for prevention of postoperative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur Heart J. 2006;27(23):2846-57. DOI: http://dx.doi. org/10.1093/eurheartj/ehl272
24. Polster P, Broekhuysen J. The adrenergic antagonism of amiodarone. Biochem Pharmacol. 1976;25(2):131-4. DOI: http://dx.doi. org/10.1016/0006-2952(76)90279-3
25. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet (London, England). 2001;357(9259):830-6. DOI: http://dx.doi.org/10.1016/S0140- 6736(00)04196-9
26. Mitchell LB, Exner DV, Wyse DG, et al. Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve
Replacement, or Repair: PAPABEAR: a randomized controlled trial. JAMA. 2005;294(24):3093-100. DOI: http://dx.doi.org/10.1001/jama.294.24.3093
27. Gillespie EL, Coleman CI, Sander S, et al. Effect of prophylactic amiodarone on clinical and economic outcomes after cardiothoracic surgery: a meta-analysis. Ann Pharmacother. 2005;39(9):1409-15. DOI: http://dx.doi.org/10.1345/aph.1E592
28. Aasbo JD, Lawrence AT, Krishnan K, Kim MH , Trohman RG. Amiodarone prophylaxis reduces major cardiovascular morbidity and length of stay after cardiac surgery: a meta-analysis. Ann lntern Med. 2005;143(5): 327-36. DOI: http://dx.doi.org/10.7326/0003-4819-143-5-200509060-00008
29. Patel AA, White CM, Gillespie EL, et al. Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm. 2006;63(9):829-37. DOI: http://dx.doi.org/10.2146/ ajhp050454
30. Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013;(1):CD003611.
31. Chatterjee S, Sardar P, Mukherjee D, et al. Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta-analysis. Pacing Clin Electrophysiol. 2013;36(8):1017-23. DOI: http://dx.doi.org/10.1111/ pace.12140
32. Zhu J, Wang C, Gao D, et al. Meta-analysis of amiodarone versus β-blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery. Intern Med J. 2012;42(10):1078-87. DOI: http://dx.doi. org/10.1111/j.1445-5994.2012.02844.x
33. DiDomenico RJ, Massad MG. Pharmacologic strategies for prevention of atrial fibrillation after open heart surgery. Ann Thorac Surg. 2005;79(2):728- 40. DOI: http://dx.doi.org/10.1016/j.athoracsur.2004.03.037
34. Reddy P, Dunn AB, White CM, et al. An economic analysis of amiodarone versus placebo for the prevention of atrial fibrillation after open heart surgery. Pharmacotherapy. 2002;22(1):75-80. DOI: http://dx.doi. org/10.1592/phco.22.1.75.33498
35. Gold MR, O’Gara PT, Buckley MJ, et al. Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol. 1996;78(9):975-9. DOI: http://dx.doi.org/10.1016/S0002- 9149(96)00519-X
36. Merrick AF, Odom NJ, Keenan DJ, et al. Comparison of propafenone to atenolol for the prophylaxis of postcardiotomy supraventricular tachyarrhythmias: a prospective trial. Eur J Cardiothorac Surg. 1995;9(3):146-9. DOI: http://dx.doi.org/10.1016/S1010-7940(05)80062-4
37. Wijeysundera DN, Beattie WS, Rao V, et al. Calcium antagonists reduce cardiovascular complications after cardiac surgery: a meta-analysis. J Am Coll Cardiol. 2003;41(9):1496-505. DOI: http://dx.doi.org/10.1016/ S0735-1097(03)00191-8
38. Solomon AJ, Berger AK, Trivedi KK, et al. The combination of propranolol and magnesium does not prevent postoperative atrial fibrillation. Ann Thorac Surg. 2000;69(1):126-9. DOI: http://dx.doi.org/10.1016/S0003- 4975(99)01187-X
39. Wistbacka JO, Koistinen J, Karlqvist KE, et al. Magnesium substitution in elective coronary artery surgery: a double-blind clinical study. J Cardiothorac Vasc Anesth. 1995;9(2):140-6. DOI: http://dx.doi. org/10.1016/S1053-0770(05)80184-3
40. Zangrillo A, Landoni G, Sparicio D, et al. Perioperative magnesium supplementation to prevent atrial fibrillation after off-pump coronary artery surgery: a randomized controlled study. J Cardiothorac Vasc Anesth. 2005;19(6):723-8. DOI: http://dx.doi.org/10.1053/j. jvca.2005.02.015
41. Miller S, Crystal E, Garfinkle M, et al. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart. 2005;91(5):618- 23. DOI: http://dx.doi.org/10.1136/hrt.2004.033811
42. De Oliveira GS Jr, Knautz JS, Sherwani S, et al. Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2012;26(4):643-50. DOI: http://dx.doi.org/10.1053/j. jvca.2012.03.012
43. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of the P-wave signalaveraged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;88(6):2618-22. DOI: http://dx.doi.org/10.1161/01. CIR.88.6.2618
44. Kirchhof P, Benussi S, Kotecha D, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893-962. DOI: http://dx.doi.org/10.1093/eurheartj/ehw210
45. Archbold RA, Schilling RJ. Atrial pacing for the prevention of atrial fibrillation after coronary artery bypass graft surgery: a review of the literature. Heart. 2004;90(2):129-33. DOI: http://dx.doi.org/10.1136/ hrt.2003.015412
46. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7(9):833-42. DOI: http://dx.doi. org/10.1111/j.1540-8167.1996.tb00596.x
47. Gillis AM, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation. 1999;99(19):2553- 8. DOI: http://dx.doi.org/10.1161/01.CIR.99.19.2553
48. Prakash A, Delfaut P, Krol RB, et al. Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol. 1998;82(10):1197-204. DOI: http://dx.doi. org/10.1016/S0002-9149(98)00604-3
49. Daubert JC, Mabo P. Atrial pacing for the prevention of postoperative atrial fibrillation: how and where to pace? J Am Coll Cardiol. 2000;35(6):1423-7.
50. Fan K, Lee K, Lau C-P. Mechanisms of biatrial pacing for prevention of postoperative atrial fibrillation--insights from a clinical trial. Card Electrophysiol Rev. 2003;7(2):147-53. DOI: http://dx.doi. org/10.1023/A:1027463516813
51. Fan K, Lee KL, Chiu CS, et al. Effects of biatrial pacing in prevention of postoperative atrial fibrillation after coronary artery bypass surgery. Circulation. 2000;102(7):755-60. DOI: http://dx.doi.org/10.1161/01. CIR.102.7.755
52. Daoud EG, Dabir R, Archambeau M, et al. Randomized, double-blind trial of simultaneous right and left atrial epicardial pacing for prevention of post-open heart surgery atrial fibrillation. Circulation. 2000;102(7):761-5. DOI: http://dx.doi.org/10.1161/01.CIR.102.7.761
53. Levy T, Fotopoulos G, Walker S, et al. Randomized controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass grafting. Circulation. 2000;102(12):1382-7. DOI: http://dx.doi.org/10.1161/01.CIR.102.12.1382
54. Greenberg MD, Katz NM, Iuliano S, et al. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol. 2000;35(6):1416-22. DOI: http://dx.doi.org/10.1016/S0735- 1097(00)00610-0
55. Gerstenfeld EP, Khoo M, Martin RC, et al. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Interv Card Electrophysiol. 2001;5(3):275-83. DOI: http://dx.doi. org/10.1023/A:1011412715439
56. Blommaert D, Gonzalez M, Mucumbitsi J, et al. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol. 2000;35(6):1411-5. DOI: http:// dx.doi.org/10.1016/S0735-1097(00)00608-2
57. Fuller JA, Adams GG, Buxton B. Atrial fibrillation after coronary artery bypass grafting. Is it a disorder of the elderly? J Thorac Cardiovasc Surg. 1989;97(6):821-5.
58. El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. J Am Coll Cardiol. 2010;55(13):1370-6. DOI: http://dx.doi.org/10.1016/j. jacc.2009.10.058
59. Phan K, Ha HSK, Phan S, et al. New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2015;48(6):817-24. DOI: http://dx.doi.org/10.1093/ejcts/ezu551
60. Chung MK. Proarrhythmic effects of post-operative pacing intended to prevent atrial fibrillation: evidence from a clinical trial. Card Electrophysiol Rev. 2003;7(2):143-6. DOI: http://dx.doi.org/10.1023/A:1027411532743
61. Rezaei Y, Gholami-Fesharaki M, Dehghani MR, et al. Statin Antiarrhythmic Effect on Atrial Fibrillation in Statin-Naive Patients Undergoing Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther. 2016;21(2):167-76. DOI: http://dx.doi. org/10.1177/1074248415602557
62. Carrascal Y, Arnold RJ, De la Fuente L, et al. Efficacy of atorvastatin in prevention of atrial fibrillation after heart valve surgery in the ROFACE trial (PROphylaxis of postoperative atrial Fibrillation AfterCardiac surgEry). J Arrhythmia. 2016;32(3):191-7. DOI: http://dx.doi. org/10.1016/j.joa.2016.01.010
63. Zheng Z, Jayaram R, Jiang L, et al. Perioperative Rosuvastatin in Cardiac Surgery. N Engl J Med. 2016;374(18):1744-53. DOI: http://dx.doi. org/10.1056/NEJMoa1507750
64. Korantzopoulos P, Kolettis T, Siogas K, et al. Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress. Med Sci Monit. 2003;9(9):RA225-9.
65. Baker WL, Coleman CI. Meta-analysis of ascorbic acid for prevention of postoperative atrial fibrillation after cardiac surgery. Am J Health Pharm. 2016;73(24):2056-66. DOI: http://dx.doi.org/10.2146/ajhp160066
66. Jahangiri A, Leifert WR, Patten GS, et al. Termination of asynchronous contractile activity in rat atrial myocytes by n-3 polyunsaturated fatty acids. Mol Cell Biochem. 2000;206(1-2):33-41. DOI: http://dx.doi. org/10.1023/A:1007025007403
67. Sarrazin J-F, Comeau G, Daleau P, et al. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs. J Am Coll Cardiol. 2007;50(15):1505- 12. DOI: http://dx.doi.org/10.1016/j.jacc.2007.05.046
68. Zhang B, Zhen Y, Tao A, et al. Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: An updated metaanalysis of randomized controlled trials. J Cardiol. 2014;63(1):53-9. DOI: http://dx.doi.org/10.1016/j.jjcc.2013.06.014
69. Mariani J, Doval HC, Nul D, et al. N-3 polyunsaturated fatty acids to prevent atrial fibrillation: updated systematic review and meta-analysis of randomized controlled trials. J Am Heart Assoc. 2013;2(1):e005033. DOI: http://dx.doi.org/10.1161/JAHA.112.005033
70. Cheruku KK, Ghani A, Ahmad F, et al. Efficacy of nonsteroidal antiinflammatory medications for prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol. 2004;7(1):13-8. DOI: http://dx.doi.org/10.1111/j.1520-037X.2004.3117.x
71. Halonen J, Halonen P, Järvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA.
2007;297(14):1562-7. DOI: http://dx.doi.org/10.1001/jama.297.14.1562
72. Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, et al. Protective ffects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth. 2011;25(1):156-65. DOI: http://dx.doi.org/10.1053/j.jvca.2010.03.015
73. Viviano A, Kanagasabay R, Zakkar M. Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery? Interact Cardiovasc Thorac Surg. 2014;18(2):225-9.
74. Trivedi C, Sadadia M. Colchicine in prevention of atrial fibrillation following cardiac surgery: systematic review and meta-analysis. Indian J Pharmacol. 2014;46(6):590-5. DOI: http://dx.doi.org/10.4103/0253-7613.144905
75. Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014;312(10):1016-23. DOI: http://dx.doi.org/10.1001/jama.2014.11026
Downloads
Published
2018-04-01
How to Cite
Ronsoni, R. de M. ., Luz Leiria, T. L. ., Silvestrini, T. L. ., Martins, L. P. ., Kruse, M. L. ., Gomes da Silva, R. ., & Glotz de Lima, G. . (2018). Prevention of atrial fibrillation after cardiac surgery. JOURNAL OF CARDIAC ARRHYTHMIAS, 31(2), 38–44. Retrieved from https://jca.emnuvens.com.br/jca/article/view/68
